Loading…
Efficacy and safety of nucleoside‐sparing regimen based on raltegravir and ritonavir‐boosted darunavir in HIV‐1‐infected treatment‐experienced patients
Jabłonowska, Elżbieta, Pulik, Piotr, Kalinowska, Anna, Gąsiorowski, Jacek, Parczewski, Miłosz, Bociąga‐Jasik, Monika, Pulik, Łukasz, Siwak, Ewa, Wójcik, Kamila
Published in Journal of medical virology (01.12.2017)
Published in Journal of medical virology (01.12.2017)
Get full text
Journal Article
Loading…
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s)
Tebas, Pablo, Zhang, Jiameng, Yarasheski, Kevin, Evans, Scott, Fischl, Margaret A, Shevitz, Abby, Feinberg, Judith, Collier, Ann C, Shikuma, Cecilia, Brizz, Barbara, Sattler, Fred
Published in Journal of acquired immune deficiency syndromes (1999) (01.06.2007)
Published in Journal of acquired immune deficiency syndromes (1999) (01.06.2007)
Get more information
Journal Article
Loading…
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110
Tebas, P., Zhang, J., Hafner, R., Tashima, K., Shevitz, A., Yarasheski, K., Berzins, B., Owens, S., Forand, J., Evans, S., Murphy, R.
Published in Journal of antimicrobial chemotherapy (01.05.2009)
Published in Journal of antimicrobial chemotherapy (01.05.2009)
Get full text
Journal Article
Loading…
Loading…
Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study)
Negredo, Eugènia, Moltó, José, Burger, David, Côté, Helene, Miró, Oscar, Ribalta, Josep, Martínez, Eva, Puig, Jordi, Ruiz, Lidia, Salazar, Juliana, López, Sònia, Montaner, Julio, Rey-Joly, Celestino, Clotet, Bonaventura
Published in Journal of acquired immune deficiency syndromes (1999) (01.01.2005)
Published in Journal of acquired immune deficiency syndromes (1999) (01.01.2005)
Get more information
Journal Article
Loading…
The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single‐arm, open‐label study of etravirine and darunavir/ritonavir as dual therapy in HIV‐1‐infected early treatment‐experienced subjects
Ruane, PJ, Brinson, C, Ramgopal, M, Ryan, R, Coate, B, Cho, M, Kakuda, TN, Anderson, D
Published in HIV medicine (01.05.2015)
Published in HIV medicine (01.05.2015)
Get full text
Journal Article
Loading…
Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals
Jackson, Akil, Else, Laura, Higgs, Christopher, Karolia, Zeenat, Khoo, Saye, Back, David, Devitt, Emma, Pozniak, Anton, Boffito, Marta
Published in HIV clinical trials (01.02.2018)
Published in HIV clinical trials (01.02.2018)
Get more information
Journal Article
Loading…
Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir-Ritonavir Plus Either Raltegravir or Tenofovir-Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial
Winston, Alan, Stöhr, Wolfgang, Antinori, Andrea, Amieva, Helene, Perré, Philippe, De Wit, Stephane, Reynes, Jacques, Gompels, Mark, dʼArminio Monforte, Antonella, Gatell, Jose-Maria, Grarup, Jesper, Pozniak, Anton, Babiker, Abdel, Raffi, François, Richert, Laura
Published in Journal of acquired immune deficiency syndromes (1999) (01.02.2017)
Published in Journal of acquired immune deficiency syndromes (1999) (01.02.2017)
Get more information
Journal Article
Loading…
Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects
Mora-Peris, B., Croucher, A., Else, L. J., Vera, J. H., Khoo, S., Scullard, G., Back, D., Winston, A.
Published in Journal of antimicrobial chemotherapy (01.06.2013)
Published in Journal of antimicrobial chemotherapy (01.06.2013)
Get full text
Journal Article
Loading…
Loading…
Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteers
La Porte, C. J. L., De Graaff‐Teulen, M. J. A., Colbers, E. P. H., Voncken, D. S., Ibanez, S. Marco, Koopmans, P. P., Hekster, Y. A., Burger, D. M.
Published in British journal of clinical pharmacology (01.12.2004)
Published in British journal of clinical pharmacology (01.12.2004)
Get full text
Journal Article
Loading…
A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results
Kozal, Michael J, Lupo, Sergio, DeJesus, Edwin, Molina, Jean-Michel, McDonald, Cheryl, Raffi, Francois, Benetucci, Jorge, Mancini, Marco, Yang, Rong, Wirtz, Victoria, Percival, Lisa, Zhang, Jenny, Zhu, Li, Arikan, Dilek, Farajallah, Awny, Nguyen, Bach-Yen, Leavitt, Randi, McGrath, Donnie, Lataillade, Max, The Spartan Study Team
Published in HIV clinical trials (01.05.2012)
Published in HIV clinical trials (01.05.2012)
Get more information
Journal Article
Loading…
Immunovirological Efficacy of Once-Daily Maraviroc Plus Ritonavir-Boosted Atazanavir After 48 Weeks in Naive HIV-Infected Patients
Pulido, Ildefonso, Genebat, Miguel, Alvarez-Rios, Ana I., De Pablo-Bernal, Rebeca S., Rafii-El-Idrissi Benhnia, Mohammed, Pacheco, Yolanda M., Ruiz-Mateos, Ezequiel, Leal, Manuel
Published in Viral immunology (01.10.2016)
Published in Viral immunology (01.10.2016)
Get full text
Journal Article
Loading…
Pharmacokinetics of Darunavir at 900 Milligrams and Ritonavir at 100 Milligrams Once Daily when Coadministered with Efavirenz at 600 Milligrams Once Daily in Healthy Volunteers
Soon, Gaik H., Shen, Ping, Yong, Eu-Leong, Pham, Paul, Flexner, Charles, Lee, Lawrence
Published in Antimicrobial Agents and Chemotherapy (01.07.2010)
Published in Antimicrobial Agents and Chemotherapy (01.07.2010)
Get full text
Journal Article
Loading…
Pharmacokinetics and safety of twice-daily atazanavir 300 mg and raltegravir 400 mg in healthy individuals
Zhu, Li, Butterton, Joan, Persson, Anna, Stonier, Michele, Comisar, Wendy, Panebianco, Deborah, Breidinger, Sheila, Zhang, Jenny, Bertz, Richard
Published in Antiviral therapy (01.01.2010)
Published in Antiviral therapy (01.01.2010)
Get full text
Journal Article
Loading…
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects
Boyd, Mark A, Aarnoutse, Rob E, Ruxrungtham, Kiat, Stek, Jr, Michael, van Heeswijk, Rolf P G, Lange, Joep M A, Cooper, David A, Phanuphak, Praphan, Burger, David M
Published in Journal of acquired immune deficiency syndromes (1999) (01.10.2003)
Published in Journal of acquired immune deficiency syndromes (1999) (01.10.2003)
Get more information
Journal Article
Loading…
Role of raltegravir in HIV-1 management
Rokas, Kristina E E, Bookstaver, P Brandon, Shamroe, Caitlin L, Sutton, S Scott, Millisor, Vanessa E, Bryant, Jacquelyn E, Weissman, Sharon B
Published in The Annals of pharmacotherapy (01.04.2012)
Published in The Annals of pharmacotherapy (01.04.2012)
Get more information
Journal Article
Loading…
Pharmacokinetic profile of maraviroc 150 mg dosed with darunavir/ritonavir once daily, with and without nucleoside analogues, in HIV‐infected subjects
Mora‐Peris, B, Croucher, A, Else, L, Khoo, S, Vera, J, Back, D, Winston, A
Published in Journal of the International AIDS Society (01.11.2012)
Published in Journal of the International AIDS Society (01.11.2012)
Get full text
Journal Article
Loading…
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience
Demeter, Lisa M, DeGruttola, Victor, Lustgarten, Stephanie, Bettendorf, Daniel, Fischl, Margaret, Eshleman, Susan, Spreen, William, Nguyen, Bach-Yen, Koval, Christine E, Eron, Joseph J, Hammer, Scott, Squires, Kathleen
Published in HIV clinical trials (01.01.2008)
Published in HIV clinical trials (01.01.2008)
Get more information
Journal Article
Loading…
Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients
Jabłonowska, Elżbieta, Siwak, Ewa, Bociąga-Jasik, Monika, Gąsiorowski, Jacek, Kalinowska, Anna, Firląg Burkacka, Ewa, Wójcik-Cichy, Kamila, Piątek, Anna, Cielniak, Iwona, Horban, Andrzej
Published in PloS one (17.01.2019)
Published in PloS one (17.01.2019)
Get full text
Journal Article